keyword
https://read.qxmd.com/read/38652480/navigating-the-tumor-microenvironment-mesenchymal-stem-cell-mediated-delivery-of-anticancer-agents
#21
REVIEW
Muhammad Ahsan Waqar, Muhammad Zaman, Muhammad ShafeeqUrRahman, Rabeel Khan, Imtiaz Majeed
Scientific knowledge of cancer has advanced greatly throughout the years, with most recent studies findings includes many hallmarks that capture disease's multifaceted character. One of the novel approach utilized for the delivery of anti-cancer agents includes mesenchymal stem cell mediated drug delivery. Mesenchymal stem cells (MSCs) are non-hematopoietic progenitor cells that may be extracted from bone marrow, tooth pulp, adipose tissue and placenta/umbilical cord blood dealing with adult stem cells. MSCs are mostly involved in regeneration of tissue, they have also been shown to preferentially migrate to location of several types of tumor in-vivo ...
April 23, 2024: Journal of Drug Targeting
https://read.qxmd.com/read/38652172/a-randomized-controlled-trial-of-two-hepatitis-a-vaccine-doses-among-adolescents-with-juvenile-idiopathic-arthritis-and-crohn-s-disease-on-immunosuppressive-therapy-a-pilot-study
#22
JOURNAL ARTICLE
Racheal Githumbi, Susan Kuhn, Carla Osiowy, Jacqueline Day, Jennifer C C deBruyn, Marvin J Fritzler, Nicole A Johnson, Otto Vanderkooi, Heinrike Schmeling
This pilot randomized controlled trial assessed the immunogenicity of paediatric versus adult Hepatitis A vaccine doses in immunosuppressed adolescents (12-15 years) with Juvenile Idiopathic Arthritis and Crohn's Disease. The study aimed to assess if a single, higher dose provides better immunogenicity, particularly beneficial before travel.
April 23, 2024: Journal of Travel Medicine
https://read.qxmd.com/read/38652046/shikonin-in-breast-cancer-treatment-a-comprehensive-review-of-molecular-pathways-and-innovative-strategies
#23
JOURNAL ARTICLE
Saeid Iranzadeh, Davood Dalil, Soroush Kohansal, Mahdi Isakhani
OBJECTIVES: Breast cancer is a prevalent disease that has a substantial impact on women's mortality rates. Shikonin, a naphthoquinone derived from Lithospermum erythrorhizon, has demonstrated substantial anticancer effects. This study aims to conduct a comprehensive review of the latest research findings regarding the therapeutic efficacy of shikonin in the context of breast cancer treatment, with a specific emphasis on elucidating the underlying molecular mechanisms. METHODS: A comprehensive literature review was conducted on shikonin and breast cancer by searching PubMed, Scopus, Web of Science, and Google Scholar databases...
April 23, 2024: Journal of Pharmacy and Pharmacology
https://read.qxmd.com/read/38651744/a-pharmacokinetic-study-comparing-the-biosimilar-hec14028-and-dulaglutide-trulicity%C3%A2-in-healthy-chinese-subjects
#24
JOURNAL ARTICLE
Xianglei Gao, Yujing Di, Yuan Lv, Yingcai Luan, Yang Xiong, Yuli Xu, Yusheng Li, Linfeng Guo, Xiaoping Li, Li Deng, Yulei Zhuang, Jie Hou
This study aimed to evaluate the pharmacokinetics (PKs), safety, and immunogenicity of the biosimilar HEC14028 compared to reference Trulicity® (dulaglutide) in healthy male Chinese subjects. This study was a single-center, randomized, open, single-dose, parallel-controlled comparative Phase I clinical trial, including a screening period of up to 14 days, a 17-day observation period after administration, and a 7-day safety follow-up period. A total of 68 healthy male subjects were randomly assigned (1:1) to the test group (HEC14028) and the reference group (dulaglutide) (single 0...
April 2024: Clinical and Translational Science
https://read.qxmd.com/read/38650939/poly-i-c-elicits-broader-and-stronger-humoral-and-cellular-responses-to-a-plasmodium-vivax-circumsporozoite-protein-malaria-vaccine-than-alhydrogel-in-mice
#25
JOURNAL ARTICLE
Tiffany B L Costa-Gouvea, Katia S Françoso, Rodolfo F Marques, Alba Marina Gimenez, Ana C M Faria, Leonardo M Cariste, Mariana R Dominguez, José Ronnie C Vasconcelos, Helder I Nakaya, Eduardo L V Silveira, Irene S Soares
Malaria remains a global health challenge, necessitating the development of effective vaccines. The RTS,S vaccination prevents Plasmodium falciparum (Pf) malaria but is ineffective against Plasmodium vivax (Pv) disease. Herein, we evaluated the murine immunogenicity of a recombinant PvCSP incorporating prevalent polymorphisms, adjuvanted with Alhydrogel or Poly I:C. Both formulations induced prolonged IgG responses, with IgG1 dominance by the Alhydrogel group and high titers of all IgG isotypes by the Poly I:C counterpart...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650936/outer-membrane-vesicles-derived-from-bordetella-pertussis-are-potent-adjuvant-that-drive-th1-biased-response
#26
JOURNAL ARTICLE
Bernarda Pschunder, Lucia Locati, Oriana López, Pablo Martin Aispuro, Eugenia Zurita, Matthew Stuible, Yves Durocher, Daniela Hozbor
For several years, we have been committed to exploring the potential of Bordetella pertussis -derived outer membrane vesicles (OMV Bp ) as a promising third-generation vaccine against the reemerging pertussis disease. The results of our preclinical trials not only confirm its protective capacity against B. pertussis infection but also set the stage for forthcoming human clinical trials. This study delves into the examination of OMV Bp as an adjuvant. To accomplish this objective, we implemented a two-dose murine schedule to evaluate the specific immune response induced by formulations containing OMV Bp combined with 3 heterologous immunogens: Tetanus toxoid (T), Diphtheria toxoid (D), and the SARS-CoV-2 Spike protein (S)...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650920/second-line-treatment-of-pancreatic-adenocarcinoma-shedding-light-on-new-opportunities-and-key-talking-points-from-clinical-trials
#27
REVIEW
Robin Imperial, Osama Mosalem, Umair Majeed, Nguyen H Tran, Mitesh J Borad, Hani Babiker
Despite improvements in overall cancer mortality, deaths related to pancreatic cancer continue to rise. Following first-line treatment, second-line options are significantly limited. Classically, first-line treatment consisted of either gemcitabine or 5-fluorouracil based systemic chemotherapy. Upon progression of disease or recurrence, subsequent second-line treatment is still gemcitabine or 5-fluorouracil based chemotherapy, depending on what was used in the first line and the timing of progression or recurrence...
2024: Clinical and Experimental Gastroenterology
https://read.qxmd.com/read/38650789/typhoid-conjugate-vaccine-a-boon-for-endemic-regions
#28
REVIEW
Nitesh Agarwal, Naveen Gupta, Nishant, Surendra H S, Trayambak Dutta, Manish Mahajan
Typhoid fever has the highest disease burden in countries in low- and middle-income countries, primarily located in Asia and Sub-Saharan Africa. Previous typhoid vaccines such as the live attenuated typhoid (Ty21a) vaccine and Vi (virulence) capsular polysaccharide vaccine had the limitation that they could not be administered with other standard childhood immunizations and were ineffective in children under two years of age. To address these shortcomings of the previous vaccines, typhoid conjugate vaccines (TCVs) were developed and prequalified by the World Health Organization...
March 2024: Curēus
https://read.qxmd.com/read/38650460/immunogenicity-and-safety-of-live-attenuated-and-recombinant-inactivated-varicella-zoster-vaccines-in-people-living-with-hiv-a-systematic-review
#29
REVIEW
Valentina Carta, Lucia Mangeri, Giorgio Tiecco, Emanuele Focà, Eugenia Quiros-Roldan, Maria Antonia De Francesco
Few papers focus their attention on VZV vaccination effectiveness among people living with HIV (PLWH). Flanking the live attenuated vaccine (VZL) available, a newly recombinant vaccine (RZV) was recently introduced and approved for HZ prevention among adults. PLWH represents a population on which a particular attention should be applied, in order to guarantee the vaccine efficacy and safety. We performed a literature search in USNLM, PubMed, PubMed Central, PMC and Cochrane Library. From all the publications found eligible, data were extracted and processed per population, vaccine type, immunogenicity and ADRs...
December 31, 2024: Human Vaccines & Immunotherapeutics
https://read.qxmd.com/read/38650361/safety-immunogenicity-and-protective-effective-of-inhaled-covid-19-vaccines-a-systematic-review-and-meta-analysis
#30
REVIEW
Gao Song, Rong Li, Meng-Qun Cheng
This study aimed to examine the safety, immunogenicity and protective effective of inhaled COVID-19 vaccines (ICVs). Literature research was done through EMBASE, Cochrane, PubMed, and Web of Science up to 10 March 2024. Pooled estimates with corresponding 95% confidence intervals (CI) were computed and compared using the random effects and common effects model. Of the 15 studies, 11 analyzed safety, 13 analyzed immunogenicity, and 3 analyzed protective effective. The results showed a favorable safety profile of ICVs for primary vaccination series, however it does not always seem to produce the expected immune response and protective effective...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38649962/extracellular-vesicle-encapsulated-nicotinamide-delivered-via-a-trans-scleral-route-provides-retinal-ganglion-cell-neuroprotection
#31
JOURNAL ARTICLE
Myungjin Kim, Jun Yong Kim, Won-Kyu Rhim, Gloria Cimaglia, Andrew Want, James E Morgan, Pete A Williams, Chun Gwon Park, Dong Keun Han, Seungsoo Rho
The progressive and irreversible degeneration of retinal ganglion cells (RGCs) and their axons is the major characteristic of glaucoma, a leading cause of irreversible blindness worldwide. Nicotinamide adenine dinucleotide (NAD) is a cofactor and metabolite of redox reaction critical for neuronal survival. Supplementation with nicotinamide (NAM), a precursor of NAD, can confer neuroprotective effects against glaucomatous damage caused by an age-related decline of NAD or mitochondrial dysfunction, reflecting the high metabolic activity of RGCs...
April 22, 2024: Acta Neuropathologica Communications
https://read.qxmd.com/read/38649894/arginine-linked-hpv-associated-e7-displaying-bacteria-derived-outer-membrane-vesicles-as-a-potent-antigen-specific-cancer-vaccine
#32
JOURNAL ARTICLE
Suyang Wang, Chao-Cheng Chen, Ming-Hung Hu, Michelle Cheng, Hsin-Fang Tu, Ya-Chea Tsai, Jr-Ming Yang, T C Wu, Chuan-Hsiang Huang, Chien-Fu Hung
BACKGROUND: Bacteria-based cancer therapy have demonstrated innovative strategies to combat tumors. Recent studies have focused on gram-negative bacterial outer membrane vesicles (OMVs) as a novel cancer immunotherapy strategy due to its intrinsic properties as a versatile carrier. METHOD: Here, we developed an Human Papillomavirus (HPV)-associated E7 antigen displaying Salmonella-derived OMV vaccine, utilizing a Poly(L-arginine) cell penetrating peptide (CPP) to enhance HPV16 E7 (aa49-67) H-2 Db and OMV affinity, termed SOMV-9RE7...
April 22, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38649867/a-pfs48-45-based-vaccine-to-block-plasmodium-falciparum-transmission-phase-1-open-label-clinical-trial
#33
JOURNAL ARTICLE
M Alkema, M J Smit, C Marin-Mogollon, K Totté, K Teelen, G J van Gemert, M van de Vegte-Bolmer, B G Mordmüller, J M Reimer, K L Lövgren-Bengtsson, R W Sauerwein, T Bousema, J Plieskatt, M Theisen, M M Jore, M B B McCall
BACKGROUND: The stalling global progress in malaria control highlights the need for novel tools for malaria elimination, including transmission-blocking vaccines. Transmission-blocking vaccines aim to induce human antibodies that block parasite development in the mosquito and mosquitoes becoming infectious. The Pfs48/45 protein is a leading Plasmodium falciparum transmission-blocking vaccine candidate. The R0.6C fusion protein, consisting of Pfs48/45 domain 3 (6C) and the N-terminal region of P...
April 23, 2024: BMC Medicine
https://read.qxmd.com/read/38649621/merkel-cell-carcinoma-integrating-epidemiology-immunology-and-therapeutic-updates
#34
REVIEW
Jürgen C Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel cell carcinoma (MCC) is a rare skin cancer characterized by neuroendocrine differentiation. Its carcinogenesis is based either on the integration of the Merkel cell polyomavirus or on ultraviolet (UV) mutagenesis, both of which lead to high immunogenicity either through the expression of viral proteins or neoantigens. Despite this immunogenicity resulting from viral or UV-associated carcinogenesis, it exhibits highly aggressive behavior. However, owing to the rarity of MCC and the lack of epidemiologic registries with detailed clinical data, there is some uncertainty regarding the spontaneous course of the disease...
April 22, 2024: American Journal of Clinical Dermatology
https://read.qxmd.com/read/38649070/validation-of-a-severe-acute-respiratory-syndrome-coronavirus-2-microneutralization-assay-for-evaluation-of-vaccine-immunogenicity
#35
JOURNAL ARTICLE
Stephanie Hamilton, Mingzhu Zhu, Shane Cloney Clark, Penny Mayes, Jen Fenner, Leah Cui, Rongman Cai, Raj Kalkeri, Louis F Fries, Melinda Pryor, Joyce Plested
As variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge, assessment of vaccine immunogenicity remains a critical factor to support continued vaccination. To this end, an in vitro microneutralization (MN50) assay was validated to quantitate SARS-CoV-2 neutralizing antibodies against prototype and variant strains (Beta, Delta, Omicron BA.1, Omicron BA.5, and XBB.1.5) in human serum. For the prototype strain, the MN50 assay met acceptance criteria for inter-/intra-assay precision, specificity, linearity, and selectivity...
April 20, 2024: Journal of Virological Methods
https://read.qxmd.com/read/38648230/live-attenuated-chikv-vaccine-with-rearranged-genome-replicates-in-vitro-and-induces-immune-response-in-mice
#36
JOURNAL ARTICLE
Irina Tretyakova, Joongho Joh, Mary Gearon, Jennifer Kraenzle, Sidney Goedeker, Ava Pignataro, Brian Alejandro, Igor S Lukashevich, Donghoon Chung, Peter Pushko
Chikungunya fever virus (CHIKV) is a mosquito-borne alphavirus that causes wide-spread human infections and epidemics in Asia, Africa and recently, in the Americas. CHIKV is considered a priority pathogen by CEPI and WHO. Despite recent approval of a live-attenuated CHIKV vaccine, development of additional vaccines is warranted due to the worldwide outbreaks of CHIKV. Previously, we developed immunization DNA (iDNA) plasmid capable of launching live-attenuated CHIKV vaccine in vivo. Here we report the use of CHIKV iDNA plasmid to prepare a novel, live-attenuated CHIKV vaccine V5040 with rearranged RNA genome...
April 22, 2024: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/38648216/beyond-the-vsg-layer-exploring-the-role-of-intrinsic-disorder-in-the-invariant-surface-glycoproteins-of-african-trypanosomes
#37
JOURNAL ARTICLE
Hagen Sülzen, Alexander N Volkov, Rob Geens, Farnaz Zahedifard, Benoit Stijlemans, Martin Zoltner, Stefan Magez, Yann G-J Sterckx, Sebastian Zoll
In the bloodstream of mammalian hosts, African trypanosomes face the challenge of protecting their invariant surface receptors from immune detection. This crucial role is fulfilled by a dense, glycosylated protein layer composed of variant surface glycoproteins (VSGs), which undergo antigenic variation and provide a physical barrier that shields the underlying invariant surface glycoproteins (ISGs). The protective shield's limited permeability comes at the cost of restricted access to the extracellular host environment, raising questions regarding the specific function of the ISG repertoire...
April 22, 2024: PLoS Pathogens
https://read.qxmd.com/read/38647488/free-radicals-generated-in-perfluorocarbon-water-liquid-liquid-interfacial-contact-electrification-and-their-application-in-cancer-therapy
#38
JOURNAL ARTICLE
Haimei Li, Zichen Wang, Xu Chu, Yi Zhao, Guangqin He, Yulin Hu, Yi Liu, Zhong Lin Wang, Peng Jiang
Electron transfer during solid-liquid contact electrification has been demonstrated to produce reactive oxygen species (ROS) such as hydroxyl radicals (• OH) and superoxide anion radicals (• O2 - ). Here, we show that such a process also occurs in liquid-liquid contact electrification. By preparing perfluorocarbon nanoemulsions to construct a perfluorocarbon-water "liquid-liquid" interface, we confirmed that electrons were transferred from water to perfluorocarbon in ultrasonication-induced high-frequency liquid-liquid contact to produce • OH and • O2 - ...
April 22, 2024: Journal of the American Chemical Society
https://read.qxmd.com/read/38647437/pharmaceutical-proteins-at-the-interfaces-and-the-role-of-albumin
#39
REVIEW
Ketki Y Velankar, Ellen S Gawalt, Yi Wen, Wilson S Meng
A critical measure of the quality of pharmaceutical proteins is the preservation of native conformations of the active pharmaceutical ingredients. Denaturation of the active proteins in any step before administration into patients could lead to loss of potency and/or aggregation, which is associated with an increased risk of immunogenicity of the products. Interfacial stress enhances protein instability as their adsorption to the air-liquid and liquid-solid interfaces are implicated in the formation of denatured proteins and aggregates...
April 22, 2024: Biotechnology Progress
https://read.qxmd.com/read/38647327/a-tetravalent-dengue-virus-like-particle-vaccine-induces-high-levels-of-neutralizing-antibodies-and-reduces-dengue-replication-in-non-human-primates
#40
JOURNAL ARTICLE
Daniel Thoresen, Kenta Matsuda, Akane Urakami, Mya Myat Ngwe Tun, Takushi Nomura, Meng Ling Moi, Yuri Watanabe, Momoko Ishikawa, Trang Thi Thu Hau, Hiroyuki Yamamoto, Yuriko Suzaki, Yasushi Ami, Jonathan F Smith, Tetsuro Matano, Kouichi Morita, Wataru Akahata
Dengue virus (DENV) represents a significant global health burden, with 50% of the world's population at risk of infection, and there is an urgent need for next-generation vaccines. Virus-like particle (VLP)-based vaccines, which mimic the antigenic structure of the virus but lack the viral genome, are an attractive approach. Here, we describe a dengue VLP (DENVLP) vaccine which generates a neutralizing antibody response against all four DENV serotypes in 100% of immunized non-human primates for up to 1 year...
April 22, 2024: Journal of Virology
keyword
keyword
49050
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.